BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/23/2020 8:36:30 AM | Browse: 750 | Download: 1496
 |
Received |
|
2020-05-07 17:47 |
|
Peer-Review Started |
|
2020-05-07 17:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-05-24 21:07 |
|
Revised |
|
2020-05-31 03:15 |
|
Second Decision |
|
2020-09-11 12:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-11 16:33 |
|
Articles in Press |
|
2020-09-11 16:33 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-10-23 01:02 |
|
Publish the Manuscript Online |
|
2020-10-23 08:36 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Safety and efficacy of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Waqas Ullah, Maryam Mukhtar, Aws Al-Mukhtar, Rehan Saeed, Margot Boigon, Donald Haas and Eduardo Rame |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Waqas Ullah, MD, Doctor, Doctor, Department of Internal Medicine, Abington Jefferson Health, 1200 Old York Road, Abington, PA 19001, United States. waqasullah.dr@gmail.com |
| Key Words |
Vericiguat; Riociguat; Soluble guanylate cyclase; Heart failure; Guanylate cyclase stimulator; |
| Core Tip |
Recently soluble guanylate cyclase (sGC) stimulators (vericiguat and riociguat) have emerged as a novel treatment for heart failure with reduced or preserved ejection fraction. Data published in literature revealed no additional benefits to guideline-based medical therapy in reducing incidence of heart failure hospitalization and mortality with sGC stimulator use. Large scale studies are required to determine the efficacy of sGC stimulators in patients with heart failure. |
| Publish Date |
2020-10-23 08:36 |
| Citation |
Ullah W, Mukhtar M, Al-Mukhtar A, Saeed R, Boigon M, Haas D, Rame E. Safety and efficacy of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis. World J Cardiol 2020; 12(10): 501-512 |
| URL |
https://www.wjgnet.com/1949-8462/full/v12/i10/501.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v12.i10.501 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
